FASLG and cancer: FasL can be cleaved by metalloproteinases such as MMP-7, ADAM10, and MMP-3 in various cell types and under various conditions, such as osteoblast apoptosis, T-cell activation, and the acquisition of chemoresistance by cancer cells.